WDKY Lexington on MSN1d
Researchers say a dangerous drug-cutting agent was detected in KentuckyExperts say ingesting the adulterant could lead to severe cardiotoxicity, ocular damage, and even sudden death.
Milestone’s NDA for CARDAMYST is currently under review at the FDA with a Prescription Drug User Fee Act (PDUFA) target date of March 27, 2025. The Company continues to advance commercial preparations ...
Repurposing amlodipine, a commonly used blood pressure medicine, could help manage attention-deficit/ hyperactivity disorder ...
A recent study from Penn State and other research institutions suggests that some of the most commonly used drugs for high ...
Anti-CD20 mAbs were originally created to treat B cell proliferative diseases such as non-Hodgkin's lymphoma and chronic ...
an L-type calcium channel blocker (LTCC), as a foundation for a novel therapy for ADHD. The findings provide robust validation of 3Z's cutting-edge high-throughput drug discovery platform and ...
Researchers discovered that these medications, while designed to lower blood pressure, may actually damage blood vessels, reduce blood flow, and increase the risk of heart failure.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback